EUVIMEDEUVIMED entdecken
Crossref

Screening Metabolic Biomarkers in KRAS Mutated Mouse Acinar and Human Pancreatic Cancer Cells via Single-Cell Mass Spectrometry

Qinlei Liu, Jiayi Lan, Sandra Martínez-Jarquín iD, Wenjie Ge, Renato Zenobi iD

Analytical Chemistry · 2024

DOI: 10.1021/acs.analchem.3c05741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Qinlei Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610065, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Ministry of Industry and Information Technology of the People's Republic of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is a highly aggressive and rapidly progressing disease, often diagnosed in advanced stages due to the absence of early noticeable symptoms. The KRAS mutation is a hallmark of pancreatic cancer, yet the underlying mechanisms driving pancreatic carcinogenesis remain elusive. Cancer cells display significant metabolic heterogeneity, which is relevant to the pathogenesis of cancer. Population measurements may obscure information about the metabolic heterogeneity among cancer cells. Therefore, it is crucial to analyze metabolites at the single-cell level to gain a more comprehensive understanding of metabolic heterogeneity. In this study, we employed a 3D-printed ionization source for metabolite analysis in both mice and human pancreatic cancer cells at the single-cell level. Using advanced machine learning algorithms and mass spectral feature selection, we successfully identified 23 distinct metabolites that are statistically significantly different in KRAS mutant human pancreatic cancer cells and mouse acinar cells bearing the oncogenic KRAS mutation. These metabolites encompass a variety of chemical classes, including organic nitrogen compounds, organic acids and derivatives, organoheterocyclic compounds, benzenoids, and lipids. These findings shed light on the metabolic remodeling associated with KRAS-driven pancreatic cancer initiation and indicate that the identified metabolites hold promise as potential diagnostic markers for early detection in pancreatic cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansMiceAnimalsProto-Oncogene Proteins p21(ras)Acinar CellsEarly Detection of CancerMutationMass SpectrometryBiomarkers

Substanzen

Proto-Oncogene Proteins p21(ras)BiomarkersKRAS protein, human

Autor:innen und Institutionen

  • Key Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610065, China.
  • Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland.
  • Advanced Materials and Healthcare Technologies Division, School of Pharmacym, University of Nottingha, University Park, NG7 2RD Nottingham, United Kingdom.
  • Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu 221004, China.
  • Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, Jiangsu 221002, China.
  • Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu 221004, China.

ORCID-Profile: Sandra Martínez-Jarquín, Renato Zenobi

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Ministry of Industry and Information Technology of the People's Republic of China
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Jiangsu Province Capability Improvement Project through Science, Technology and Education

Zitieren

APA

Liu, Q., Lan, J., Martínez-Jarquín, S., Ge, W., & Zenobi, R. (2024). Screening Metabolic Biomarkers in KRAS Mutated Mouse Acinar and Human Pancreatic Cancer Cells via Single-Cell Mass Spectrometry. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.3c05741

Vancouver

Liu Q, Lan J, Martínez-Jarquín S, Ge W, Zenobi R. Screening Metabolic Biomarkers in KRAS Mutated Mouse Acinar and Human Pancreatic Cancer Cells via Single-Cell Mass Spectrometry. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.3c05741

BibTeX
@article{Liu2024,
  author = {Liu, Qinlei and Lan, Jiayi and Martínez-Jarquín, Sandra and Ge, Wenjie and Zenobi, Renato},
  title = {Screening Metabolic Biomarkers in KRAS Mutated Mouse Acinar and Human Pancreatic Cancer Cells via Single-Cell Mass Spectrometry},
  journal = {Analytical Chemistry},
  year = {2024},
  doi = {10.1021/acs.analchem.3c05741}
}
Kostenlos starten →